Multiple Sclerosis Journal Articles

• Impact of the COVID-19 Pandemic on People Living With Migraine The results of this study revealed that the global COVID-19 pandemic resulted in both negative and positive impacts for people living with migraine.
  Headache, April 22, 2022
• mRNA COVID-19 Vaccine Effectiveness in the Immunocompromised This CDC report reveals that mRNA COVID-19 vaccines are less effective in immunocompromised persons, supporting the recommendation for administration of a third dose of mRNA vaccine in this group.
  Morbidity & Mortality Weekly Report, January 26, 2022
• Removal and Capsulectomy Outcomes for Breast Implant Illness What do we know about the outcomes of patients with breast implant illness who undergo removal with capsulectomy?
  Plastic Reconstructive Surgery-Global Open (PRS Global Open), October 05, 2021
• Deep Grey Matter Injury in MS: A NAIMS Consensus Statement The NAIMS Cooperative has released a consensus statement regarding the relevance of deep grey matter damage in multiple sclerosis.
  Brain, September 28, 2021
• AI in Functional Urology: How It May Shape the Future Find out how artificial intelligence technology could apply to the field of functional urology.
  Current Opinion in Urology, September 20, 2021
• Association Between Atopic Dermatitis and Autoimmune Diseases This large population-based study explored the association between atopic dermatitis and a wide spectrum of autoimmune diseases. Which autoimmune disorders had the strongest association?
  The British Journal of Dermatology, September 15, 2021
• An Overview of Male Osteoporosis While osteoporosis is often thought of as a disease of postmenopausal women, it can affect men as well. Review the risk factors, causes, and management of male osteoporosis in this article.
  U.S. Pharmacist, August 25, 2021
• Sjogren's Syndrome With Nervous System Injury and Cryptococcosis This case details a rare form of neural involvement in Sjogren's syndrome, combined with pulmonary and osseous cryptococcosis due to long-term use of high-dose corticosteroids and immunosuppressants.
  Journal of Medical Case Reports, August 12, 2021
• Outcome of a COVID-19 Outbreak in a SNF With Black Residents An analysis of the course of a COVID-19 outbreak in an urban skilled nursing facility highlights a proactive management strategy that can help improve outcomes for these patients.
  Journal of the American Geriatrics Society, July 16, 2021
• Statins Do More Than Lower Cholesterol-Depending on Diet? A new study presents a novel perspective on the cholesterol-independent effects of statins, and suggests that these effects may vary depending on diet.
  Circulation, July 16, 2021
• Quantitative MRI Towards Clinical Application in MS Learn how quantitative MRI addresses the shortcomings of conventional MRI in terms of stratification of patients with multiple sclerosis, assessment of disease progression, and treatment response.
  Brain, July 16, 2021
• Cannabinoid-based Medications for Pain The popularity of cannabinoid-based medications for treating chronic pain is growing, but the interest in their use may be outpacing the evidence supporting their analgesic benefits
  Current Psychiatry, July 15, 2021
• Biologics for Moderate-to-Severe Psoriasis With Comorbidities This paper provides evidence-based recommendations for the use of biologics for the treatment of moderate-to-severe psoriasis in patients with psoriasis and cormorbid conditions, including COVID-19.
  American Journal of Clinical Dermatology, July 08, 2021
• Cognitive Impairment and Cerebral Glucose Metabolism in COVID-19 Using neuropsychological testing and functional imaging, this study aimed to comprehensively characterize the neurological sequelae of COVID-19.
  Brain, June 01, 2021
• Characterizing Chronic Pain Phenotypes in Multiple Sclerosis This study aimed to characterize and compare pain phenotypes in MS in terms of pain type and intensity, chronic overlapping pain conditions, and medication use and associated relief.
  Pain, May 19, 2021
• Neurogranin as a Novel Biomarker in Alzheimer's Disease This study evaluated the diagnostic value of CSF neurogranin and alpha-synuclein as biomarkers of synapsis damage in patients with Alzheimer disease.
  Laboratory Medicine, April 26, 2021
• Stratification of Patients Based on the NPSI Utilizing the Neuropathic Pain Symptom Inventory, a new algorithm stratifies patients into phenotypes corresponding to specific combinations of neuropathic symptoms.
  Pain, April 23, 2021
• Mesenchymal Stem Cell Transplantation in Progressive MS This study compared the the therapeutic efficacy of mesenchymal stem cell transplantation to sham treatment in patients with active or worsening progressive multiple sclerosis.
  Brain, February 22, 2021
• The Microglial Component of Amyotrophic Lateral Sclerosis The authors explore evidence for the contribution of microglia to neurotoxicity and neuroprotection in amyotrophic lateral sclerosis. Might elucidation of these processes lead to novel therapeutics?
  Brain, February 08, 2021
• Headache as a Cardinal Symptom of Coronavirus Disease 2019 This study aimed to describe the characteristics of pain and associated symptoms in patients presenting to the ED with COVID-19-related headache, with and without a history of migraine.
  Headache, December 24, 2020